| Claudin-5: gatekeeper of neurological function |
41 |
| A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
34 |
| Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers |
31 |
| Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier |
18 |
| Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases |
17 |
| Benchmarking in vitro tissue-engineered blood-brain barrier models |
16 |
| Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis |
16 |
| An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons |
15 |
| The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema |
15 |
| Claudin-12 is not required for blood-brain barrier tight junction function |
15 |
| Analysis of convective and diffusive transport in the brain interstitium |
14 |
| Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation |
14 |
| Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D |
14 |
| Is bulk flow plausible in perivascular, paravascular and paravenous channels? |
14 |
| Zika virus crosses an in vitro human blood brain barrier model |
13 |
| Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease |
11 |
| The need for mathematical modelling of spatial drug distribution within the brain |
11 |
| Dispersion in porous media in oscillatory flow between flat plates: applications to intrathecal, periarterial and paraarterial solute transport in the central nervous system |
11 |
| Hydraulic resistance of periarterial spaces in the brain |
11 |
| Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate |
10 |
| Pulsatile flow drivers in brain parenchyma and perivascular spaces: a resistance network model study |
10 |
| The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model |
10 |
| Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models |
9 |
| The effect of an adenosine - A(2A) agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma |
8 |
| Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop |
8 |
| Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis |
7 |
| Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients |
7 |
| Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients |
7 |
| Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration |
6 |
| Cerebellar tonsil ectopia measurement in type I Chiari malformation patients show poor inter-operator reliability |
6 |
| The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients |
5 |
| Spinal CSF flow in response to forced thoracic and abdominal respiration |
5 |
| Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells |
5 |
| Uncertainty quantification of parenchymal tracer distribution using random diffusion and convective velocity fields |
5 |
| Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats |
5 |
| A perfusion bioreactor-based 3D model of the subarachnoid space based on a meningeal tissue construct |
4 |
| Effect of extradural constriction on CSF flow in rat spinal cord |
4 |
| Comorbidity of diabetes mellitus in idiopathic normal pressure hydrocephalus: a systematic literature review |
4 |
| Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain |
4 |
| Fluid outflow in the rat spinal cord: the role of perivascular and paravascular pathways |
4 |
| The endo-lysosomal system of bEnd.3 and hCMEC/D3 brain endothelial cells |
3 |
| Characteristics of the cerebrospinal fluid pressure waveform and craniospinal compliance in idiopathic intracranial hypertension subjects |
3 |
| B waves: a systematic review of terminology, characteristics, and analysis methods |
3 |
| Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model |
3 |
| Patient-specific cranio-spinal compliance distribution using lumped-parameter model: its relation with ICP over a wide age range |
2 |
| Enhanced in vitro model of the CSF dynamics |
2 |
| Paradigm-shift: radiological changes in the asymptomatic iNPH-patient to be: an observational study |
2 |
| Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease |
2 |
| Effect of blood contamination of cerebrospinal fluid on amino acids, biogenic amines, pterins and vitamins |
2 |
| Blood-brain and blood-cerebrospinal fluid barrier permeability in spontaneously hypertensive rats |
2 |
